Fauci misled Congress when he denied the NIH funded gain-of-function research in Wuhan.

As the U.S. life sciences real estate sector recovers from a challenging year in 2024, other markets across the globe, particularly in China and Europe, are gaining steam.

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception ... Every step of the way needs to be tested in the laboratory, in live cells, animal,s or humans. This ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

With accessible diagnostics at the forefront of the biotech industry, Cue Health has been paving the way since 2010 to provide patients with the tools and resources to effectively manage their own ...

The Cambridge, Massachusetts-based biotech is closing “following careful consideration of potential paths forward and strategic factors,” HC CEO and cofounder Leslie Williams said in an ...

Credit: Rocket Lab webcast WASHINGTON — Rocket Lab has completed the deployment of a constellation of Internet-of-Things satellites for French company Kinéis with a launch March 17. An Electron ...

In the cutting-edge world of biotechnology, your lab's proprietary information is its lifeblood. As such, ensuring the security of your intellectual property, research data, and trade secrets is ...

A Boston biotech try­ing to bring trans­fer RNA (tR­NA) bi­ol­o­gy to the drug de­vel­op­ment field has shut­tered op­er­a­tions, End­points News has learned.